These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13226052)

  • 21. Construction of a dual beam heated infrared cell.
    NEU JT
    J Opt Soc Am; 1953 Jun; 43(6):520-1. PubMed ID: 13070115
    [No Abstract]   [Full Text] [Related]  

  • 22. The development of a beam-walking test and its use in measuring development of balance in children.
    SEASHORE HG
    Res Q; 1947 Dec; 18(4):246-59. PubMed ID: 18898569
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of beam trypsin inhibitors on thromboplastic properties of trypsin and hypochlorite-treated trypsin.
    BOWMAN DE
    Proc Soc Exp Biol Med; 1954 Jul; 86(3):491-4. PubMed ID: 13194700
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2).
    Glossmann JP; Josting A; Pfistner B; Paulus U; Engert A;
    Ann Hematol; 2002 Aug; 81(8):424-9. PubMed ID: 12223998
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
    Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
    Smith RJ; Sweetenham JW
    Exp Hematol; 1995 Dec; 23(14):1581-8. PubMed ID: 8542950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
    Selker RG; Shapiro WR; Burger P; Blackwood MS; Arena VC; Gilder JC; Malkin MG; Mealey JJ; Neal JH; Olson J; Robertson JT; Barnett GH; Bloomfield S; Albright R; Hochberg FH; Hiesiger E; Green S;
    Neurosurgery; 2002 Aug; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
    Wang EH; Chen YA; Corringham S; Bashey A; Holman P; Ball ED; Carrier E
    Bone Marrow Transplant; 2004 Oct; 34(7):581-7. PubMed ID: 15273714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Utilization of contiguous orthogonal beams in the treatment of semi-deep-seated tumors].
    SWYNGEDAUW J; GIAUX G; TOISON G
    J Radiol Electrol Arch Electr Medicale; 1953; 34(5-6):426-9. PubMed ID: 13097513
    [No Abstract]   [Full Text] [Related]  

  • 30. [The principle of convergent beam irradiation and the effects of a modified spacer tube].
    FETZER H; KELLER L
    Strahlentherapie; 1954 Aug; 94(4):586-95. PubMed ID: 13226039
    [No Abstract]   [Full Text] [Related]  

  • 31. BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma.
    Veeraputhiran M; Jain T; Deol A; Ayash L; Kim S; Dyson G; Bhutani D; Lum LG; Ratanatharathorn V; Uberti JP; Abidi MH
    Clin Lymphoma Myeloma Leuk; 2015 Sep; 15(9):531-5. PubMed ID: 26166312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group.
    Pfreundschuh MG; Rueffer U; Lathan B; Schmitz N; Brosteanu O; Hasenclever D; Haas R; Kirchner H; Koch P; Kuse R
    J Clin Oncol; 1994 Mar; 12(3):580-6. PubMed ID: 8120557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directed beam therapy; a rotational therapy chair.
    LOW-BEER BV
    Am J Roentgenol Radium Ther; 1951 Dec; 66(6):956-60. PubMed ID: 14894749
    [No Abstract]   [Full Text] [Related]  

  • 34. [On pre-irradiation of the parametrium in operable cervical carcinoma with moving beam irradiation].
    van HAI ; HELD F; SCHWARZ R
    Radiobiol Radiother (Berl); 1963; 4():107-11. PubMed ID: 13951963
    [No Abstract]   [Full Text] [Related]  

  • 35. Absorption measurements for broad beams of 1- and 2-million-volt X-rays.
    SINGER G; BRAESTRUP CB; WYCKOFF HO
    J Res Natl Bur Stand (1934); 1946 Aug; 37(2):147-50. PubMed ID: 20999090
    [No Abstract]   [Full Text] [Related]  

  • 36. Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation.
    Truelove E; Fox C; Robinson S; Pearce R; Perry J; Kirkland K; McQuaker G; Pagliuca A; Johnson P; Russell N; Cook G;
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):483-8. PubMed ID: 25490180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary report.
    Phillips GL; Abboud CN; Bernstein SH; Friedberg JW; Ifthikharuddin JJ; Lancet JE; Liesveld JL; Spreng E; Johnson V; Chapman M; Vesole DH
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):59-61. PubMed ID: 15726525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma.
    William BM; Loberiza FR; Whalen V; Bierman PJ; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):417-23. PubMed ID: 23773453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of solid atmospheric pollutants upon the transmission of a collimated beam of infra-red radiation.
    DENNIS WL
    Int J Air Water Pollut; 1961 Nov; 5():34-45. PubMed ID: 13885468
    [No Abstract]   [Full Text] [Related]  

  • 40. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.
    Schmitz N; Pfistner B; Sextro M; Sieber M; Carella AM; Haenel M; Boissevain F; Zschaber R; Müller P; Kirchner H; Lohri A; Decker S; Koch B; Hasenclever D; Goldstone AH; Diehl V; ;
    Lancet; 2002 Jun; 359(9323):2065-71. PubMed ID: 12086759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.